期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

过敏性结膜炎药物治疗研究进展 被引量：4

Process on Drug Treatment of Allergic Conjunctivitis
下载PDF
导出
摘要 过敏性结膜炎是过敏性眼病中的最常见类型。现依据近年发表的相关文献,对过敏性结膜炎药物治疗的研究进展作一综述。 Objective Allergic conjunctivitis is one of the most common allergic eye diseases. This paper summarizes the drug treatment of allergic conjunctivitis.
作者 王玉玲 韩保萍 杜国辉
机构地区 山东博士伦福瑞达制药有限公司 山东大学药学院
出处 《食品与药品》 CAS 2009年第5期48-51,共4页 Food and Drug
关键词 过敏性结膜炎 药物治疗 研究进展 allergic conjunctivitis drug treatment progress
分类号 R777.31 [医药卫生—眼科]
  • 相关文献

参考文献31

  • 1Bielory L, Lien K W, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis[J]. Drugs, 2005, 65(2): 215-228.
  • 2Orfeo V, Vardaro A, Lena P, et al. Comparison of emedastine 0.05 % or nedocromil sodium 2% eyedrops and placebo in controlling local reactions in subjects with allergic conjunctivitis [J]. Eur J Ophthalmol, 2002, 12(4): 262-266.
  • 3Netland P A, Leahy C, Krenzer K L. Emedastine ophthalmic solution 0.05 % versus levocabastine ophthalmic suspension 0.05 % in the treatment of allergic conjunctivitis using the conjunctival allergen challenge mode[J]. Am J Ophthalmol, 2000, 130 (6): 717-723.
  • 4Endre L. The prompt effect of emedastine eye drop and the safety of its permanent use in children suffering from acute seasonal allergic conjunctivitis[J]. Orv Hetil, 2007, 148(6): 251-254.
  • 5Fujishima H, Fukagawa K, Takano Y, et al. The early efficacy of topical levocabastine in patients with allergic conjunctivitis[J]. Allergol Int, 2006, 55(3): 301-303.
  • 6Takamura E, Nomura K, Fujishima H, et al. Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis[J]. Allergol Int, 2006, 55(2): 57-165.
  • 7施文,王永铭,朱琦,孙新怀,王康孙,张皙.盐酸左卡巴斯汀滴眼液治疗过敏性结膜炎68例[J].中国新药杂志,2003,12(8):657-659. 被引量：4
  • 8Donshik P C, Pearlman D, Pinnas J, et al. Efficacy and safety of ketorolac tromethamine 0.5 % and levocabastine 0.05 %: a multicenter comparison in patients with seasonal allergic conjunctivitis[J]. Adv Ther, 2000, 17(2): 94-102.
  • 9陈世铭,马志中,赵光喜,吴惠群,吴君卿,施锦娜.4％色甘酸钠滴眼液治疗变应性结膜炎[J].新药与临床,1994,13(5):264-266. 被引量：6
  • 10Adefule-Ositelu A O, Onakoya A O, Olasimbo O O, et al. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital[J]. Niger Postgrad Med J, 2006, 13( 1): 35-40.

二级参考文献5

  • 1.中华人民共和国卫生部药政司新药(西药)临床研究指导原则汇编[S].,1993.52-53.
  • 2Dechant KL, Goa KL. Levocabastine: a review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis[J]. Drugs, 1991,41 (2): 202-224.
  • 3Noble S, McTavish D. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis [J]. Drugs, 1995,50 ( 6 ) : 1032 -1049.
  • 4中华人民共和国卫生部药政司.新药(西药)临床研究指导原则汇编[S].,1993.52—53.
  • 5胡肇纹,赵长松,邱良秀.色甘酸钠滴眼液治疗变态反应性结膜炎初步观察[J]眼科新进展,1987(01).

共引文献8

同被引文献27

  • 1刘祖国,肖启国.过敏性结膜炎的诊治[J].中华眼科杂志,2004,40(7):500-502. 被引量：63
  • 2刘祖国,姚勇,孙秉基,孙兴怀,谢汉平,王红,万修华,崔敏,陈龙山,张梅.过敏性结膜炎的临床特点[J].中国实用眼科杂志,2004,22(9):694-697. 被引量：94
  • 3马海霞,刘光伟,赵勇.γ型干扰素、CD4^+CD25^+调节性T细胞与自身免疫病[J].免疫学杂志,2007,23(1):103-106. 被引量：8
  • 4孙声桃,徐筠,魏秋彩.过敏性结膜炎的结膜印迹细胞学改变[J].眼科新进展,2007,27(8):618-618. 被引量：2
  • 5Berdy GJ, Hedqvist B.Ocular allergic disorders and dry eye disease: asslociations, diagnostic dilemmas, and management[J].Acta Ophthalmol Scand suppl,2000,78 ( s230 ): 32-37.
  • 6Berdy GJ, Stoppe] JO, Epstein AB.Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthahnic solution and loteprednnl etabnnate 0.2% ophthahnic suspension in the conjunctival allergen challenge model[J].Clin Ther,2002,24 ( 6 ) : 918-929.
  • 7Mah FS, OB'rien T, Kim T, et al.Evaluation of the effects of olopatadine ophthalmic solution 0.2% on the ocular surface of patients with allergic conjunctivitis and dry eye[J].CurrMed Res Opin, 2008,24 ( 2 ) : 441-447.
  • 8Abelson MB, Gomes PJ, Pasquine T, et al.Efficacy of olopatadine ophthalmic solutinn 0.2% in reducing signs and symptoms of allergic conjmwtivitis[J]. Allergy Asthma Proc, 2007,28 ( 4 ) : 427-433.
  • 9Swamy BN, Chilov M, McClellan K, et al.Topical non-steroidal anti- inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data[J].Ophthalmic Epidemiol, 2007,14 ( 5 ) : 3 l 1-319.
  • 10王莉莉.门诊急性结膜炎患者的有关因素调查[J].广西医学,2008,30(2):300-300. 被引量：12

引证文献4

二级引证文献43

食品与药品
2009年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部